BLGO:OTCQB

BioLargo Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Its core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Its business approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

BioLargo Inc. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.

Recent Articles:

New EPA Forever Chemical Rules Could Favor This Clean Tech Co.

  ()
BioLargo Inc. may be uniquely positioned to take advantage of new U.S. federal drinking water standards announced Wednesday meant to limit exposure to so-called "forever chemicals." Find out why one technical analyst says this stock is headed for a bull market.

Cleantech Co. Sees Revenues Increase 108% YoY

  ()
BioLargo Inc. announced its revenues increased by 108% year-over-year from 2022 to 2023, according to its annual report.

Co.'s Stock Rises as 'Forever Chemicals' Investigated in Texas

  ()
The controversy over dangerous PFAS, also known as "forever chemicals," has hit two small farms in Texas. Find out why one analyst thinks a company with a solution is headed for a bull market as its stock rises.
Tags:  Technology

Former EPA Exec Joins Co.'s 'Forever Chemicals' Fight

  ()
Almost half of the nation's tap water is affected by so-called "forever chemicals." Find out if these dangerous substances have been found in waters near you.
Tags:  Technology

Bust-out Cleantech Firm Adds Industry Luminary To Board

  ()
By hiring the longest-serving CEO of the Metropolitan Water District of Southern California, BioLargo, Inc. has positioned itself as a leader of a nascent industry.

Cleantech Stocks 2023 Revenues Doubled 2022

Research Report
  ()
BioLargo Inc.'s 2023 revenue was more than doubled from that in 2022, according to an Oakridge Financial research note.

More Articles


Expert Comments:

Richard Ryan, Oak Ridge Financial

(4/4/24)
"BioLargo Inc. announced that 2023 revenues more than doubled the level the company reported in 2022, making it the second year in a row that revenues have grown at that rate. BioLargo maintained gross margin at 50%, doubled shareholders' equity, all while maintaining minimal debt and ending the year with $3.5M in cash."

Clive Maund, CliveMaund.com

(2/14/24)
"The fundamentals of BioLargo Inc. are superb with everything coming together in a positive manner after many years of work. So ultimately, the company's stock is believed headed much higher."

Richard Ryan, Oak Ridge Financial

(1/29/24)
"BioLargo Inc. announced that its 2023 revenues more than doubled the level it reported in 2022, making it the second year in a row that revenues have grown at that rate. . .the company's results continue to be driven by Pooph sales, its pet odor control product line that is being sold through national retailers like Amazon, Walmart, Chewy and a growing list of other retailers."

Clive Maund, CliveMaund.com

(1/25/24)
"Over the past couple of days after a steep advance, BioLargo Inc. has reacted back a shade. But the dramatic dieback in volume is bullish and suggests that this steep uptrend is not done yet."

Clive Maund, CliveMaund.com

(12/22/23)
"BioLargo Inc. is at a good entry point here, and the company is rated a Strong Conservative Buy for all time frames. . .it is considered to have substantial upside from here with the capacity to make faster gains than many consider possible, especially if there is anything to the sodium battery story."

Richard Ryan, Oak Ridge Financial

(12/8/23)
"BioLargo Inc. has finished its rollout of Pooph into Walmart locations and expects that Ikigai, its major distribution partner, can secure contracts for more than 20K retail stores by 2023E. . .Pooph appears to be on the cusp for significant revenue expansion, which has been reaffirmed through Amazon as Pooph averages over 90K bottles purchased each month (as of Dec. 7, 2023) with a Best Seller ranking of No. 1 in Dog Deodorizers."

Experts Following This Company

Michael Mathison, Analyst – Singular Research
Clive Maund – CliveMaund.com
Richard Ryan – Oak Ridge Financial
headshot of Chris Temple
Chris Temple, Editor and Publisher – The National Investor

Company News 

4/15/2024 – BioLargo PFAS Removal Technology Meets New US Drinking Water Standards

4/2/2024 – BioLargo Achieved 108% Year-Over-Year Revenue Growth in 2023

2/20/2024 – BioLargo Adds Larry Dick, Prominent Water Industry Veteran, to Board of Its Water Equipment Subsidiary

2/12/2024 – BioLargo Recruits Sally Gutierrez, Former EPA Senior Advisor, for the Board of its Water Equipment and PFAS Solutions Company

2/5/2024 – Jeffrey Kightlinger, Recognized Water Industry Leader, Joins Board of BioLargo's Water Equipment and PFAS Solutions Company

1/29/2024 – BioLargo Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment

1/22/2024 – BioLargo Doubles Annual Revenues - Again

Important Disclosures
BioLargo Inc. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases. The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content. Billboard advertising monthly fees range from $3,000 to $5,000. This landing page contains a summary of the company that was prepared by that company. Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company. The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports. There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page. Readers should conduct their own research for all information publicly available concerning the company. This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.

streetwise book logo Streetwise Company Fact Sheet

2024/4/16 6:33:51

(BLGO:OTCQB)

Analyst coverage

Singular ResearchMichael Mathison
Oak Ridge FinancialRichard Ryan

Newsletter coverage

Company News

View Latest News

Streetwise Reports Articles

04/11/2024 - View Article
04/05/2024 - View Article
03/04/2024 - View Article
02/21/2024 - View Article
02/12/2024 - View Article

streetwise book logoStreetwise - BioLargo Inc. Ownership Overview*

BioLargo Inc. (BLGO:OTCQB)

*Share Structure as of 2/20/2024
Investing Highlights
 
Invest-prove-partner business model that leverages credible partners to maximize impact
 
Unrivaled technologies to solve challenges in emerging environmental markets
 
Heading toward profitability, with average QoQ revenue growth of +25% over past two years
catalyst Calendar
Q4
2023
www.pooph.com, pet odor control product expanding nationwide through retailers
Q1
2024
Major PFAS treatment projects underway, best technology to meet new regulations
Q2
2024
Launch of safe, affordable long-duration energy storage battery technology